Jefferies Financial Group began coverage of MSCI stock, while Raymond James raised its target price and Morgan Stanley reaffirmed its rating.
4 reports, 2 independent
Updated Sep 5
Gone quiet
- Reports
- 4
- Developments
- 1
- Repetition
- 75%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Jefferies Financial Group began coverage of MSCI stock, while Raymond James raised its target price and Morgan Stanley reaffirmed its rating.
Who's involved
What this event is mainly aboutKeep exploring
Part of
Morgan Stanley, MSCI, Raymond James Financial, and Benzinga are involved in the process of receiving and issuing analyst ratings and research reports on company stocks.Also in this story
- Morgan Stanley and Raymond James Financial issued conflicting analyst ratings (raise/downgrade) for V2X, Inc. on August 18, 2026.
- Morgan Stanley raised price targets and ratings for Ultragenyx Pharmaceutical.
The entities involved
-
Jefferies Financial Group
American financial services company
-
MSCI
American financial service provider
-
Raymond James Financial
American Investment Bank and Financial Services Firm
Related events
- Jefferies Financial Group began coverage, Morgan Stanley set a high price target, and Keefe, Bruyette & Woods increased price objectives, with MarketBeat reporting the average stock rating.
- Jefferies Financial Group initiated coverage on Moody's shares, and Morgan Stanley subsequently raised its price target for the company.
- Multiple financial firms, including Raymond James, Jefferies, and RBC, raised price targets for CM stock on October 24, 2026.
- Jefferies Financial Group set a price target for Navitas Semiconductor stock.
- Raymond James Financial increased its price target and gave a strong-buy rating for TMX Group.